{"DataElement":{"publicId":"2769114","version":"2","preferredName":"Contributing Cause of Death Reason Type","preferredDefinition":"A description of the contributing cause of death.","longName":"2769112v1.5:2768974v3.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2769112","version":"1.5","preferredName":"Contributing Cause of Death Reason","preferredDefinition":"The part played by somebody or something in bringing about an end or result._The circumstance or condition that results in the death of a living being._An explanation of the cause of some phenomenon or action.","longName":"4731571v1.0:2390595v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"4731571","version":"1","preferredName":"Contribution Cause of Death","preferredDefinition":"The part played by somebody or something in bringing about an end or result.:The circumstance or condition that results in the death of a living being.","longName":"C61412:C81239","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contribution","conceptCode":"C61412","definition":"The part played by somebody or something in bringing about an end or result.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cause of Death","conceptCode":"C81239","definition":"The circumstance or condition that results in the death of a living being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10659971-65A2-DCF8-E050-BB89AD430723","latestVersionIndicator":"Yes","beginDate":"2015-03-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-03","modifiedBy":"ONEDATA","dateModified":"2015-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2390595","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE52ECB4-C378-617F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-16","modifiedBy":"ONEDATA","dateModified":"2005-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"106ABE1E-90C0-A499-E050-BB89AD431C9F","latestVersionIndicator":"Yes","beginDate":"2015-03-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-03","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"7/21/17 jk Added CSI per Round 5 finalization task; CDE already Standard/NCI Standard context.  3/14/17 Ownership transferred from NHLBI to NCI Standards per Robinette Renner.  Used in NCI Standard CDEs.  jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2768974","version":"3","preferredName":"Cause of Death Reason Type","preferredDefinition":"The circumstance or condition that results in the death of a living being._An explanation of the cause of some phenomenon or action._Type; a subdivision of a particular kind of thing.","longName":"2768974v3.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Coronary artery disease (atherosclerosis)","valueDescription":"Coronary Disease","ValueMeaning":{"publicId":"2760269","version":"1","preferredName":"Coronary Disease","longName":"2760269","preferredDefinition":"An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coronary Artery Disease","conceptCode":"C26732","definition":"Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF5CBC6-3CA7-1060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CFF3-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Congestive Heart Failure","valueDescription":"Congestive heart failure","ValueMeaning":{"publicId":"2565944","version":"1","preferredName":"Congestive heart failure","longName":"2565944","preferredDefinition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congestive Heart Failure","conceptCode":"C3080","definition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CFFD-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Chronic Obstructive Pulmonary Disease","valueDescription":"Chronic Obstructive Pulmonary Disease","ValueMeaning":{"publicId":"3385484","version":"1","preferredName":"Chronic Obstructive Pulmonary Disease","longName":"3385484","preferredDefinition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Obstructive Pulmonary Disease","conceptCode":"C3199","definition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9A72D8B-F30F-0839-E040-BB89AD437342","latestVersionIndicator":"Yes","beginDate":"2012-02-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D007-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Chronic liver disease","valueDescription":"Stigmata of Chronic Liver Disease","ValueMeaning":{"publicId":"3837931","version":"1","preferredName":"Stigmata of Chronic Liver Disease","longName":"3837931","preferredDefinition":"Signs of chronic liver disease which include jaundice, ascites, palmar erythema, spider hemangiomas, gynecomastia, and encephalopathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stigmata of Chronic Liver Disease","conceptCode":"C82996","definition":"Signs of chronic liver disease which include jaundice, ascites, palmar erythema, spider hemangiomas, gynecomastia, and encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6932-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D011-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Cardiovascular Disorder","valueDescription":"Cardiovascular Disorder","ValueMeaning":{"publicId":"2630208","version":"1","preferredName":"Cardiovascular Disorder","longName":"2630208","preferredDefinition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels).  Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension.  Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiovascular Disorder","conceptCode":"C2931","definition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels). Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension. Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E8C3390-BBE2-1B34-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-04-20","modifiedBy":"COLBERTM","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D01B-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Cardiopulmonary Arrest","valueDescription":"Cardiopulmonary Arrest","ValueMeaning":{"publicId":"3604293","version":"1","preferredName":"Cardiopulmonary Arrest","longName":"3604293","preferredDefinition":"Cessation of breathing and/or cardiac function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiopulmonary Arrest","conceptCode":"C50483","definition":"Cessation of breathing and/or cardiac function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-BADE-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D025-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Aspiration Pneumonia","valueDescription":"Aspiration Pneumonia","ValueMeaning":{"publicId":"3604295","version":"1","preferredName":"Aspiration Pneumonia","longName":"3604295","preferredDefinition":"Pneumonia secondary to aspiration of liquids and gastric contents into the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aspiration Pneumonitis","conceptCode":"C34932","definition":"Inflammation of the lungs due to the inhalation of solid or liquid material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-BB04-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D02F-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Unclassified infection / Infection NOS","valueDescription":"Not Otherwise Specified Unclassified Infection","ValueMeaning":{"publicId":"3837944","version":"1","preferredName":"Not Otherwise Specified Unclassified Infection","longName":"3837944","preferredDefinition":"Not characterized in any other way.: Not arranged or included in any specific grouping.: A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Unclassified","conceptCode":"C64486","definition":"Not arranged or included in any specific grouping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6A46-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D039-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Sepsis","valueDescription":"Septicemia","ValueMeaning":{"publicId":"2946181","version":"1","preferredName":"Septicemia","longName":"2946181","preferredDefinition":"The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Septicemia","conceptCode":"C3364","definition":"The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746BFDBA-4A29-B144-E040-BB89AD4341DF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D043-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Respiratory failure","valueDescription":"Respiratory Failure","ValueMeaning":{"publicId":"2946095","version":"1","preferredName":"Respiratory Failure","longName":"2946095","preferredDefinition":"Impaired gas exchange by the respiratory system resulting in hypoxemia and decreased oxygenation of the tissues that may be associated with increased arterial levels of carbon dioxide. Causes include chronic obstructive pulmonary disease, asthma, emphysema, acute respiratory distress syndrome, pneumonia, pulmonary edema, pneumothorax, and congestive heart failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Respiratory Failure","conceptCode":"C26872","definition":"The significant impairment of gas exchange within the lungs resulting in hypoxia, hypercarbia, or both, to the extent that organ tissue perfusion is severely compromised. Causes include chronic obstructive pulmonary disease, asthma, emphysema, acute respiratory distress syndrome, pneumonia, pulmonary edema, pneumothorax, and congestive heart failure. Treatment requires intubation and mechanical ventilation until the time the lungs recover sufficient function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-679E-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D04D-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Pulmonary Embolism","valueDescription":"Pulmonary Embolism","ValueMeaning":{"publicId":"2770974","version":"1","preferredName":"Pulmonary Embolism","longName":"2770974","preferredDefinition":"The closure of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Embolism","conceptCode":"C50713","definition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F2DD1F-DD5A-0AF3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D057-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Pneumonia NOS","valueDescription":"Not Otherwise Specified Pneumonia","ValueMeaning":{"publicId":"3837945","version":"1","preferredName":"Not Otherwise Specified Pneumonia","longName":"3837945","preferredDefinition":"Not characterized in any other way.: Inflammation of the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pneumonia","conceptCode":"C3333","definition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6A8A-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D061-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Persistence or recurrence of underlying disease","valueDescription":"Persistent Disease Or Recurrent Disease","ValueMeaning":{"publicId":"3837946","version":"1","preferredName":"Persistent Disease Or Recurrent Disease","longName":"3837946","preferredDefinition":"A disease that does not go to remission despite treatment.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The return of a disease after a period of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Persistent Disease","conceptCode":"C90169","definition":"A disease that does not go to remission despite treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6AB1-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D06B-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Parkinson's Disease","valueDescription":"Parkinson's Disease","ValueMeaning":{"publicId":"3604284","version":"1","preferredName":"Parkinson's Disease","longName":"3604284","preferredDefinition":"A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parkinson Disease","conceptCode":"C26845","definition":"A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-B91F-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D075-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Non-protocol cancer therapy","valueDescription":"Non-Protocol Cancer Treatment","ValueMeaning":{"publicId":"3837947","version":"1","preferredName":"Non-Protocol Cancer Treatment","longName":"3837947","preferredDefinition":"Treatment not specified in a protocol.: Any intervention for management of a malignant neoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Protocol","conceptCode":"C25590","definition":"Treatment not specified in a protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cancer Therapeutic Procedure","conceptCode":"C16212","definition":"Any intervention for management of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6AE8-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D07F-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Natural causes","valueDescription":"Natural Cause of Death","ValueMeaning":{"publicId":"3837948","version":"1","preferredName":"Natural Cause of Death","longName":"3837948","preferredDefinition":"A description for something that exists in or is produced by nature, and is not artificial or man-made.: The circumstance or condition that results in the death of a living being.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Natural","conceptCode":"C85060","definition":"A description for something that exists in or is produced by nature, and is not artificial or man-made.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cause of Death","conceptCode":"C81239","definition":"The circumstance or condition that results in the death of a living being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6B0E-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D089-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Myocardial infarction","valueDescription":"Myocardial infarction","ValueMeaning":{"publicId":"2569449","version":"1","preferredName":"Myocardial infarction","longName":"2569449","preferredDefinition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area. (Dorland, 27th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocardial Infarction","conceptCode":"C27996","definition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC56-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-26","modifiedBy":"ALAIS","dateModified":"2006-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D093-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"HIV / AIDS","valueDescription":"Human Immunodeficiency Virus And/Or Acquired Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3838716","version":"1","preferredName":"Human Immunodeficiency Virus And/Or Acquired Immunodeficiency Syndrome","longName":"3838716","preferredDefinition":"Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.: Used to indicate that either or both of two items or options may be valid.: A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Immunodeficiency Virus","conceptCode":"C14219","definition":"The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E34BBF24-FDA3-768F-E040-BB89AD4334A3","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-06","modifiedBy":"ONEDATA","dateModified":"2013-08-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-D0E8-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"New malignancy","valueDescription":"New Malignant Neoplasm","ValueMeaning":{"publicId":"4732513","version":"1","preferredName":"New Malignant Neoplasm","longName":"4732513","preferredDefinition":"Having no previous example or precedent or parallel; of a kind not seen before.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10694E6B-6DAC-79A6-E050-BB89AD433E9A","latestVersionIndicator":"Yes","beginDate":"2015-03-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27070EDE-B88F-4CAC-E050-BB89AD435F4A","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Diffuse alveolar hemorrhage (DAH)","valueDescription":"Diffuse Pulmonary Alveolar Hemorrhage","ValueMeaning":{"publicId":"5021904","version":"1","preferredName":"Diffuse Pulmonary Alveolar Hemorrhage","longName":"5021904","preferredDefinition":"widely spread; not localized or confined.: Bleeding in the alveoli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse","conceptCode":"C14175","definition":"Widely spread; not localized or confined.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pulmonary Alveolar Hemorrhage","conceptCode":"C116334","definition":"Bleeding in the alveoli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2047C974-49B6-BBB9-E050-BB89AD4355F1","latestVersionIndicator":"Yes","beginDate":"2015-09-21","endDate":null,"createdBy":"SORENSENS","dateCreated":"2015-09-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27070EDE-B8A3-4CAC-E050-BB89AD435F4A","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Diffuse alveolar damage (without hemorrhage)","valueDescription":"Widespread Alveolar Pneumocyte Damage Present","ValueMeaning":{"publicId":"5021903","version":"1","preferredName":"Widespread Alveolar Pneumocyte Damage Present","longName":"5021903","preferredDefinition":"A morphologic finding indicating the presence of extensive injury of the alveolar pneumocytes in a lung tissue sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Widespread Alveolar Pneumocyte Damage Present","conceptCode":"C96237","definition":"A morphologic finding indicating the presence of extensive injury of the alveolar pneumocytes in a lung tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2047C974-4990-BBB9-E050-BB89AD4355F1","latestVersionIndicator":"Yes","beginDate":"2015-09-21","endDate":null,"createdBy":"SORENSENS","dateCreated":"2015-09-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27070EDE-B8B7-4CAC-E050-BB89AD435F4A","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Thrombotic microangiopathy (TMA) (Thrombotic thrombocytopenic purpura (TTP)/Hemolytic Uremic Syndrome (HUS))","valueDescription":"Thrombotic Microangiopathy","ValueMeaning":{"publicId":"4733314","version":"1","preferredName":"Thrombotic Microangiopathy","longName":"4733314","preferredDefinition":"The syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombotic Microangiopathy","conceptCode":"C62605","definition":"A microvascular coagulopathy that may result from systemic vascular endothelial injury triggering the development of a procoagulant state, activation of the complement cascade, and microthrombi formation. Signs may include hemolytic anemia, thrombocytopenia, hypertension and renal dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A242-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27180513-78C4-5A6C-E050-BB89AD436275","beginDate":"2015-12-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-17","modifiedBy":"ONEDATA","dateModified":"2015-12-17","deletedIndicator":"No"},{"value":"Recurrence / persistence / progression of disease","valueDescription":"Recurrence And/Or Persistent And/Or Progressive Disease","ValueMeaning":{"publicId":"5086931","version":"1","preferredName":"Recurrence And/Or Persistent And/Or Progressive Disease","longName":"5086931","preferredDefinition":"To come back or to return.: Used to indicate that either or both of two items or options may be valid.: Retained; never-ceasing.: Used to indicate that either or both of two items or options may be valid.: Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrence","conceptCode":"C3352","definition":"Happening again (especially at regular intervals).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Persistent","conceptCode":"C43623","definition":"Retained; never-ceasing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27180513-78D4-5A6C-E050-BB89AD436275","latestVersionIndicator":"Yes","beginDate":"2015-12-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27180513-78ED-5A6C-E050-BB89AD436275","beginDate":"2015-12-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-17","modifiedBy":"ONEDATA","dateModified":"2015-12-17","deletedIndicator":"No"},{"value":"Adult respiratory distress syndrome (ARDS) (other than IPS)","valueDescription":"Adult Respiratory Distress Syndrome","ValueMeaning":{"publicId":"2769013","version":"1","preferredName":"Adult Respiratory Distress Syndrome","longName":"2769013","preferredDefinition":"fulminant pulmonary interstitial and alveolar edema resulting from diffuse infection, shock, or trauma of the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Respiratory Distress Syndrome","conceptCode":"C3353","definition":"Progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery. Cases of neonatal respiratory distress syndrome are not included in this definition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9AFC-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21F2EDF9-95A4-417C-E050-BB89AD433B00","beginDate":"2008-07-28","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-10-12","modifiedBy":"ONEDATA","dateModified":"2015-10-12","deletedIndicator":"No"},{"value":"Central nervous system (CNS) failure","valueDescription":"Central Nervous System Failure","ValueMeaning":{"publicId":"2769009","version":"1","preferredName":"Central Nervous System Failure","longName":"2769009","preferredDefinition":"The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A75-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21F2EDF9-95B8-417C-E050-BB89AD433B00","beginDate":"2008-07-28","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-10-12","modifiedBy":"ONEDATA","dateModified":"2015-10-12","deletedIndicator":"No"},{"value":"Multiple organ failure","valueDescription":"Multiple Organ Failure","ValueMeaning":{"publicId":"2768995","version":"1","preferredName":"Multiple Organ Failure","longName":"2768995","preferredDefinition":"A progressive condition usually characterized by combined failure of the lungs, liver, kidney, and clotting mechanisms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Organ Failure","conceptCode":"C75568","definition":"Complete impairment of two or more organs or organ systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-989F-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21F2EDF9-95CC-417C-E050-BB89AD433B00","beginDate":"2008-09-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-10-12","modifiedBy":"ONEDATA","dateModified":"2015-10-12","deletedIndicator":"No"},{"value":"Veno-occlusive disease (VOD) / sinusoidal obstruction syndrome (SOS)","valueDescription":"Hepatic Veno-Occlusive Disease","ValueMeaning":{"publicId":"2793925","version":"1","preferredName":"Hepatic Veno-Occlusive Disease","longName":"2793925","preferredDefinition":"Blockage of the small- or medium-sized hepatic veins due to nonthrombotic subendothelial edema which may progress to fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinusoidal Obstruction Syndrome","conceptCode":"C26793","definition":"A disorder characterized by inflammation and damage of the hepatic sinusoidal endothelial cells of the hepatic venules that leads to venular occlusion and hepatocellular necrosis. It is most often a conditioning-related toxicity that results as a complication of hematopoietic stem cell transplantation (HSCT). It has also been described in populations of individuals who have ingested pyrrolizidine plant alkaloids. The clinical signs and symptoms include hyperbilirubinemia, hepatomegaly, and fluid retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"594FA4A3-3296-6DA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-10-15","modifiedBy":"COLBERTM","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21F2EDF9-95F4-417C-E050-BB89AD433B00","beginDate":"2008-08-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-10-12","modifiedBy":"ONEDATA","dateModified":"2015-10-12","deletedIndicator":"No"},{"value":"Cardiovascular accident","valueDescription":"Cerebrovascular Accident","ValueMeaning":{"publicId":"3837932","version":"1","preferredName":"Cerebrovascular Accident","longName":"3837932","preferredDefinition":"A sudden loss of neurologic function secondary to hemorrhagic or ischemia in the brain parenchyma due to a vascular event. Infarction or hemorrhage may be demonstrated either directly by imaging,laboratory, or pathologic examination in patients with symptom duration less than 24 hours, or inferred by symptoms lasting greater than or equal to 24 hours (or fatal within 24 hours) that cannot be attributed to another cause.  Diagnostic tests include CT scan, MRI, angiography, and EEG to locate and evaluate the extent of the hemorrhagic or ischemic damage in the brain parenchyma, coagulation studies, complete blood count, comprehensive metabolic panel, and urinalysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-695F-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CDD7-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Dementia  (including Alzheimer's disease)","valueDescription":"Dementia","ValueMeaning":{"publicId":"3165569","version":"1","preferredName":"Dementia","longName":"3165569","preferredDefinition":"An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dementia","conceptCode":"C4786","definition":"Loss of intellectual abilities interfering with an individual's social and occupational functions. Causes include Alzheimer's disease, brain injuries, brain tumors, and vascular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96FCF74F-C196-EAB7-E040-BB89AD437850","latestVersionIndicator":"Yes","beginDate":"2010-12-09","endDate":null,"createdBy":"LUY","dateCreated":"2010-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CDE1-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Viral infection","valueDescription":"Viral Infection","ValueMeaning":{"publicId":"2768976","version":"1","preferredName":"Viral Infection","longName":"2768976","preferredDefinition":"A general term for diseases produced by viruses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Viral Infection","conceptCode":"C3439","definition":"Any disease caused by a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-95DA-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CDF5-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Vascular, not otherwise specified","valueDescription":"Vascular Not Otherwise Specified","ValueMeaning":{"publicId":"2768978","version":"1","preferredName":"Vascular Not Otherwise Specified","longName":"2768978","preferredDefinition":"Relating to or containing blood vessels.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vascular","conceptCode":"C13311","definition":"Relating to or containing blood vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-962B-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE09-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Thromboembolic","valueDescription":"Thromboembolism","ValueMeaning":{"publicId":"2768980","version":"1","preferredName":"Thromboembolism","longName":"2768980","preferredDefinition":"Obstruction of a vessel by a blood clot that has been transported from a distant site by the blood stream.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thromboembolism","conceptCode":"C28195","definition":"Occlusion of the lumen of a vessel by a thrombus that has migrated from a distal site via the blood stream.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9653-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE13-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Suicide","valueDescription":"Suicide","ValueMeaning":{"publicId":"2572283","version":"1","preferredName":"Suicide","longName":"2572283","preferredDefinition":"The act of ending one's own life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Suicide","conceptCode":"C3394","definition":"The act of ending one's own life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E768-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-01","modifiedBy":"COOPERM","dateModified":"2008-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE1D-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Renal failure","valueDescription":"Renal Failure","ValueMeaning":{"publicId":"2768982","version":"1","preferredName":"Renal Failure","longName":"2768982","preferredDefinition":"Acute or chronic condition, characterized by the inability of the kidneys to adequately filter the blood substances, resulting in uremia and electrolyte imbalances.  Acute renal failure is usually associated with oliguria or anuria, hyperkalemia, and pulmonary edema.  Chronic renal failure is irreversible and requires hemodialysis.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Failure","conceptCode":"C4376","definition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-968B-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"COLBERTM","dateModified":"2023-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE27-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Graft rejection or failure","valueDescription":"Graft Rejection","ValueMeaning":{"publicId":"2779293","version":"1","preferredName":"Graft Rejection","longName":"2779293","preferredDefinition":"Failure of transplanted tissue to become functional or operational, often as a result of destruction by the host's immune system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Failure","conceptCode":"C75570","definition":"Failure of transplanted tissue to become functional or operational, often as a result of destruction by the host's immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55EE40E7-CD96-5FD7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-09-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE31-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Pulmonary failure","valueDescription":"Pulmonary Failure","ValueMeaning":{"publicId":"2768984","version":"1","preferredName":"Pulmonary Failure","longName":"2768984","preferredDefinition":"Relating to the lungs.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-96DC-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE45-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Pulmonary hemorrhage","valueDescription":"Pulmonary Hemorrhage","ValueMeaning":{"publicId":"2750111","version":"1","preferredName":"Pulmonary Hemorrhage","longName":"2750111","preferredDefinition":"Relating to the lungs.: Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D5CE735-FC29-136E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE4F-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Protozoal infection","valueDescription":"Protozoal Infection","ValueMeaning":{"publicId":"2573841","version":"1","preferredName":"Protozoal Infection","longName":"2573841","preferredDefinition":"Infections with unicellular organisms of the subkingdom PROTOZOA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protozoal Infection","conceptCode":"C34953","definition":"An infection that is caused by protozoans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ED7E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-28","modifiedBy":"COOPERM","dateModified":"2008-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE59-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Infection, organism not identified","valueDescription":"Infection Organism Not Identified","ValueMeaning":{"publicId":"2768993","version":"1","preferredName":"Infection Organism Not Identified","longName":"2768993","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.: A living thing, such as an animal, a plant, a bacterium, or a fungus.: The finding is not present, but a value of 'none' cannot be unequivocally established absence in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Organism","conceptCode":"C14250","definition":"A living entity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Identified","conceptCode":"C48661","definition":"The finding is not present, but a value of 'none' cannot be unequivocally established absence in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-984D-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE63-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Organ failure, not otherwise specified","valueDescription":"Organ Failure Not Otherwise Specified","ValueMeaning":{"publicId":"2768994","version":"1","preferredName":"Organ Failure Not Otherwise Specified","longName":"2768994","preferredDefinition":"A part of the body that performs a specific function.  For example, the heart is an organ.: loss of ability to function normally.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Organ","conceptCode":"C13018","definition":"A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues.  An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9876-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"COLBERTM","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE6D-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Liver failure (not VOD)","valueDescription":"Liver Failure","ValueMeaning":{"publicId":"2768996","version":"1","preferredName":"Liver Failure","longName":"2768996","preferredDefinition":"A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-98C7-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE77-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Intracranial hemorrhage","valueDescription":"Intracranial Hemorrhage","ValueMeaning":{"publicId":"2768998","version":"1","preferredName":"Intracranial Hemorrhage","longName":"2768998","preferredDefinition":"Bleeding within the cranium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracranial Hemorrhage","conceptCode":"C50438","definition":"Bleeding within the cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-98EF-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE81-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Hemorrhage, not otherwise specified","valueDescription":"Hemorrhage Not Otherwise Specified","ValueMeaning":{"publicId":"2769002","version":"1","preferredName":"Hemorrhage Not Otherwise Specified","longName":"2769002","preferredDefinition":"Bleeding or escape of blood from a vessel.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9966-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE8B-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Hemorrhagic cystitis","valueDescription":"Hemorrhage Cystitis","ValueMeaning":{"publicId":"2769003","version":"1","preferredName":"Hemorrhage Cystitis","longName":"2769003","preferredDefinition":"Bleeding or escape of blood from a vessel.: Inflammation of the urinary bladder. (Dorland, 27th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cystitis","conceptCode":"C26738","definition":"Inflammation of the urinary bladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-998E-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE95-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Gastrointestinal hemorrhage","valueDescription":"Gastrointestinal Hemorrhage","ValueMeaning":{"publicId":"2769006","version":"1","preferredName":"Gastrointestinal Hemorrhage","longName":"2769006","preferredDefinition":"(GAS-tro-in-TES-tih-nul) GI.  Refers to the stomach and intestines.: Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal","conceptCode":"C13359","definition":"Pertaining to the stomach and intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A03-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CE9F-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Fungal infection","valueDescription":"Fungal Infection","ValueMeaning":{"publicId":"2769007","version":"1","preferredName":"Fungal Infection","longName":"2769007","preferredDefinition":"An infection caused by eukaryotic heterotrophic organisms that live as saprobes or parasites, including mushrooms, yeasts, smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi refer to those that grow as multicellular colonies (mushrooms and molds).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fungal Infection","conceptCode":"C3245","definition":"An infection caused by a fungus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A28-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CEA9-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Chronic GVHD","valueDescription":"Chronic Graft Versus Host Disease","ValueMeaning":{"publicId":"2769010","version":"1","preferredName":"Chronic Graft Versus Host Disease","longName":"2769010","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A9A-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"KUMMEROA","dateModified":"2023-10-30","changeDescription":null,"administrativeNotes":"2023.10.30 Alt VM added per ticket request CADSR0003010. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CEBD-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Bacterial infection","valueDescription":"Bacterial Infection","ValueMeaning":{"publicId":"2769012","version":"1","preferredName":"Bacterial Infection","longName":"2769012","preferredDefinition":"infections and associated diseases by bacteria, general or unspecified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bacterial Infection","conceptCode":"C2890","definition":"An acute infectious disorder that is caused by gram positive or gram negative bacteria; representative examples include pneumococcal, streptococcal, salmonella, and meningeal infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9AD7-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CEC7-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Acute GVHD","valueDescription":"Acute Graft Versus Host Disease","ValueMeaning":{"publicId":"2769014","version":"1","preferredName":"Acute Graft Versus Host Disease","longName":"2769014","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9B21-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CED1-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Accidental death","valueDescription":"Accident Death","ValueMeaning":{"publicId":"2769015","version":"1","preferredName":"Accident Death","longName":"2769015","preferredDefinition":"An unforeseen and unplanned event or circumstance frequently causing loss or injury.: The absence of life or state of being dead.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accident","conceptCode":"C34340","definition":"An unforeseen and unplanned event or circumstance frequently causing loss or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9B49-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CEDB-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Gastrointestinal (GI) failure (not liver)","valueDescription":"Gastrointestinal Failure","ValueMeaning":{"publicId":"2769005","version":"1","preferredName":"Gastrointestinal Failure","longName":"2769005","preferredDefinition":"(GAS-tro-in-TES-tih-nul) GI.  Refers to the stomach and intestines.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal","conceptCode":"C13359","definition":"Pertaining to the stomach and intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-99DE-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CEEF-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Disseminated intravascular coagulation (DIC)","valueDescription":"DIC","ValueMeaning":{"publicId":"2769008","version":"1","preferredName":"DIC","longName":"2769008","preferredDefinition":"Disseminated intravascular coagulation (DIC) is a pathological process in the body where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased the risk of hemorrhage.  There are a variety of causes of DIC, all usually causing the release of chemicals into the blood that instigates the coagulation. (from Wikipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disseminated Intravascular Coagulation","conceptCode":"C2992","definition":"A pathological process where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased risk of hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A4D-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF0D-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Other cause","valueDescription":"Other Reason","ValueMeaning":{"publicId":"2762648","version":"1","preferredName":"Other Reason","longName":"2762648","preferredDefinition":"Not otherwise specified.: An explanation of the cause of some phenomenon or action.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510F7405-014B-02E3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF17-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Other hemorrhage","valueDescription":"Other Hemorrhage","ValueMeaning":{"publicId":"2774534","version":"1","preferredName":"Other Hemorrhage","longName":"2774534","preferredDefinition":"Not otherwise specified.: Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"545D72C7-6643-2B4F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF21-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Other infection","valueDescription":"Other Infection","ValueMeaning":{"publicId":"2774535","version":"1","preferredName":"Other Infection","longName":"2774535","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"545D72C7-6668-2B4F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF2B-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Other organ failure","valueDescription":"Other Organ Failure","ValueMeaning":{"publicId":"2774537","version":"1","preferredName":"Other Organ Failure","longName":"2774537","preferredDefinition":"Not otherwise specified.: A part of the body that performs a specific function.  For example, the heart is an organ.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Organ","conceptCode":"C13018","definition":"A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues.  An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"545D72C7-66B9-2B4F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF3F-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Other vascular","valueDescription":"Other Vascular","ValueMeaning":{"publicId":"2774538","version":"1","preferredName":"Other Vascular","longName":"2774538","preferredDefinition":"Not otherwise specified.: Relating to or containing blood vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Vascular","conceptCode":"C13311","definition":"Relating to or containing blood vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"545D72C7-66DE-2B4F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF49-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Cardiac failure","valueDescription":"Heart Failure","ValueMeaning":{"publicId":"2718360","version":"1","preferredName":"Heart Failure","longName":"2718360","preferredDefinition":"Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements or the ability to do so only at an elevated filling pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heart Failure","conceptCode":"C50577","definition":"Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42D5D049-038F-6FD0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF53-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Prior malignancy","valueDescription":"Prior Malignant Neoplasm","ValueMeaning":{"publicId":"2774527","version":"1","preferredName":"Prior Malignant Neoplasm","longName":"2774527","preferredDefinition":"Earlier in time or order.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"545BF7ED-22A1-164E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF67-A898-E050-BB89AD4354B4","beginDate":"2008-07-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Influenza","valueDescription":"Influenza","ValueMeaning":{"publicId":"3604288","version":"1","preferredName":"Influenza","longName":"3604288","preferredDefinition":"An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Influenza","conceptCode":"C53482","definition":"An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-B9AD-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF85-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Herpes","valueDescription":"Herpes","ValueMeaning":{"publicId":"3837928","version":"1","preferredName":"Herpes","longName":"3837928","preferredDefinition":"Any inflammatory skin disease caused by a herpesvirus and characterized by the formation of small vesicles in clusters.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Herpes","conceptCode":"C50583","definition":"Any inflammatory skin disease caused by a herpesvirus and characterized by the formation of small vesicles in clusters.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-688F-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF8F-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Hepatitis","valueDescription":"Hepatitis","ValueMeaning":{"publicId":"3257061","version":"1","preferredName":"Hepatitis","longName":"3257061","preferredDefinition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis","conceptCode":"C3095","definition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8AA35B8-AD6E-E3A8-E040-BB89AD43122A","latestVersionIndicator":"Yes","beginDate":"2011-07-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CF99-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Due to this disease","valueDescription":"Primary Disease or Disorder","ValueMeaning":{"publicId":"3837929","version":"1","preferredName":"Primary Disease or Disorder","longName":"3837929","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-68BC-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CFA3-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Due to protocol treatment, drug-related","valueDescription":"Therapy-Related Toxicity","ValueMeaning":{"publicId":"3340602","version":"1","preferredName":"Therapy-Related Toxicity","longName":"3340602","preferredDefinition":"The finding of bodily harm due to the poisonous effects associated with the action or administration of therapeutic agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy-Related Toxicity","conceptCode":"C42607","definition":"The finding of bodily harm due to the poisonous effects associated with the action or administration of therapeutic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5411922-05F3-6FAE-E040-BB89AD4318EA","latestVersionIndicator":"Yes","beginDate":"2011-12-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CFAD-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Diabetes Mellitus","valueDescription":"Diabetes Mellitus","ValueMeaning":{"publicId":"3292684","version":"1","preferredName":"Diabetes Mellitus","longName":"3292684","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D82E-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CFB7-A898-E050-BB89AD4354B4","beginDate":"2013-08-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CFC1-A898-E050-BB89AD4354B4","beginDate":"2013-08-13","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Radiation IP","valueDescription":"Radiation Therapy Interstitial Pneumonia","ValueMeaning":{"publicId":"3854250","version":"1","preferredName":"Radiation Therapy Interstitial Pneumonia","longName":"3854250","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.: Inflammation of interstitial lung tissue, usually associated with infection.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3D82D79-0864-7EED-E040-BB89AD433B9E","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CFCB-A898-E050-BB89AD4354B4","beginDate":"2013-08-13","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Interstitial Pneumonia (IP) NOS","valueDescription":"Not Otherwise Specified Interstitial Pneumonia","ValueMeaning":{"publicId":"3854251","version":"1","preferredName":"Not Otherwise Specified Interstitial Pneumonia","longName":"3854251","preferredDefinition":"Not characterized in any other way.: Inflammation of interstitial lung tissue, usually associated with infection.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3D82D79-088A-7EED-E040-BB89AD433B9E","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CFD5-A898-E050-BB89AD4354B4","beginDate":"2013-08-13","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"BCNU IP","valueDescription":"Carmustine Interstitial Pneumonia","ValueMeaning":{"publicId":"3854252","version":"1","preferredName":"Carmustine Interstitial Pneumonia","longName":"3854252","preferredDefinition":"An antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  This agent also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04): Inflammation of interstitial lung tissue, usually associated with infection.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carmustine","conceptCode":"C349","definition":"An antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  This agent also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3D82D79-08B0-7EED-E040-BB89AD433B9E","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CFDF-A898-E050-BB89AD4354B4","beginDate":"2013-08-13","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Failure to Thrive","valueDescription":"Failure to Thrive","ValueMeaning":{"publicId":"3854253","version":"1","preferredName":"Failure to Thrive","longName":"3854253","preferredDefinition":"A clinical finding indicating less than normal growth in an infant or child, or a state of global decline in an adult.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Failure to Thrive","conceptCode":"C107587","definition":"A clinical finding indicating less than normal growth in an infant or child, or a state of global decline in an adult.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3D82D79-08D5-7EED-E040-BB89AD433B9E","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21873A93-CFE9-A898-E050-BB89AD4354B4","beginDate":"2013-08-13","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"ONEDATA","dateModified":"2015-10-07","deletedIndicator":"No"},{"value":"Cytokine release syndrome","valueDescription":"Cytokine Release Syndrome","ValueMeaning":{"publicId":"2946552","version":"1","preferredName":"Cytokine Release Syndrome","longName":"2946552","preferredDefinition":"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine Release Syndrome","conceptCode":"C78251","definition":"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74A40B1A-E861-30F2-E040-BB89AD4307C8","latestVersionIndicator":"Yes","beginDate":"2009-09-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27098005-2251-E32E-E050-BB89AD4303C2","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Other pulmonary syndrome (excluding pulmonary hemorrhage)","valueDescription":"Other Interstitial Pneumonia","ValueMeaning":{"publicId":"5085511","version":"1","preferredName":"Other Interstitial Pneumonia","longName":"5085511","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Inflammation of interstitial lung tissue, usually associated with infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27098005-225E-E32E-E050-BB89AD4303C2","latestVersionIndicator":"Yes","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27098005-2277-E32E-E050-BB89AD4303C2","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Idiopathic pneumonia syndrome (IPS)","valueDescription":"Idiopathic Pneumonia Syndrome","ValueMeaning":{"publicId":"5085512","version":"1","preferredName":"Idiopathic Pneumonia Syndrome","longName":"5085512","preferredDefinition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Idiopathic Pneumonia Syndrome","conceptCode":"C62590","definition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27098005-2281-E32E-E050-BB89AD4303C2","latestVersionIndicator":"Yes","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27098005-229A-E32E-E050-BB89AD4303C2","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Pneumonitis due to other virus","valueDescription":"Other Virus Interstitial Pneumonia","ValueMeaning":{"publicId":"5085513","version":"1","preferredName":"Other Virus Interstitial Pneumonia","longName":"5085513","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.: Inflammation of interstitial lung tissue, usually associated with infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Virus","conceptCode":"C14283","definition":"An infectious agent which consists of two parts, genetic material and a protein coat. These organisms lack independent metabolism, and they must infect the cells of other types of organisms to reproduce. Most viruses are capable of passing through fine filters that retain bacteria, and are not visible through a light microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27098005-22A8-E32E-E050-BB89AD4303C2","latestVersionIndicator":"Yes","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27098005-22C1-E32E-E050-BB89AD4303C2","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Pneumonitis due to Cytomegalovirus (CMV)","valueDescription":"Cytomegalovirus Interstitial Pneumonia","ValueMeaning":{"publicId":"5085514","version":"1","preferredName":"Cytomegalovirus Interstitial Pneumonia","longName":"5085514","preferredDefinition":"A genus of the family herpesviridae, subfamily betaherpesvirinae, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions.: Inflammation of interstitial lung tissue, usually associated with infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytomegalovirus","conceptCode":"C14196","definition":"A genus of the family herpesviridae, subfamily betaherpesvirinae, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27098005-22CE-E32E-E050-BB89AD4303C2","latestVersionIndicator":"Yes","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"27098005-22E7-E32E-E050-BB89AD4303C2","beginDate":"2015-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2015-12-16","modifiedBy":"ONEDATA","dateModified":"2015-12-16","deletedIndicator":"No"},{"value":"Neurotoxicity","valueDescription":"Neurotoxicity","ValueMeaning":{"publicId":"3211303","version":"1","preferredName":"Neurotoxicity","longName":"3211303","preferredDefinition":"A group of neurologic disorders caused by damage to the nervous system following exposure to pharmacologic, biologic, and chemical agents. Examples of neurotoxins include chemotherapy agents, radiation treatment, heavy metals, pesticides, and food additives.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurotoxicity Syndrome","conceptCode":"C27961","definition":"A group of neurologic disorders caused by damage to the nervous system following exposure to pharmacologic, biologic, and chemical agents. Examples of neurotoxins include chemotherapy agents, radiation treatment, heavy metals, pesticides, and food additives.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-EAFB-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5DA0C9C7-CB24-705E-E053-F662850A0888","beginDate":"2017-11-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-10","modifiedBy":"ONEDATA","dateModified":"2017-11-10","deletedIndicator":"No"},{"value":"COVID-19 (SARS-CoV-2)","valueDescription":"SARS Coronavirus 2","ValueMeaning":{"publicId":"7215671","version":"1","preferredName":"SARS Coronavirus 2","longName":"7215671","preferredDefinition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2","conceptCode":"C169076","definition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A13B6E15-724F-71AC-E053-F662850A052E","latestVersionIndicator":"Yes","beginDate":"2020-03-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-03-19","modifiedBy":"COLBERTM","dateModified":"2020-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A1D6AFFF-1EDE-6141-E053-F662850A4FA2","beginDate":"2020-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-03-27","modifiedBy":"ONEDATA","dateModified":"2020-03-27","deletedIndicator":"No"},{"value":"Tumor lysis syndrome","valueDescription":"Tumor Lysis Syndrome","ValueMeaning":{"publicId":"2944002","version":"1","preferredName":"Tumor Lysis Syndrome","longName":"2944002","preferredDefinition":"A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Lysis Syndrome","conceptCode":"C3425","definition":"A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-112A-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B81AB94B-92FD-38ED-E053-4EBD850A0AE7","beginDate":"2021-01-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-01-04","modifiedBy":"ONEDATA","dateModified":"2021-01-04","deletedIndicator":"No"},{"value":"Neurotoxicity (ICANS)","valueDescription":"Immune Effector Cell Associated Neurotoxicity Syndrome","ValueMeaning":{"publicId":"7544420","version":"1","preferredName":"Immune Effector Cell Associated Neurotoxicity Syndrome","longName":"7544420","preferredDefinition":"Neurotoxicity associated with immune effector cell therapy. It may be characterized by aphasia, altered level of consciousness, motor weakness, seizures, and cerebral edema.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Effector Cell Associated Neurotoxicity Syndrome","conceptCode":"C162909","definition":"Neurotoxicity associated with immune effector cell therapy. It may be characterized by aphasia, altered level of consciousness, motor weakness, seizures, and cerebral edema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B81AB94B-9309-38ED-E053-4EBD850A0AE7","latestVersionIndicator":"Yes","beginDate":"2021-01-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-01-04","modifiedBy":"ONEDATA","dateModified":"2021-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B81AB94B-9322-38ED-E053-4EBD850A0AE7","beginDate":"2021-01-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-01-04","modifiedBy":"ONEDATA","dateModified":"2021-01-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4731570","version":"1","preferredName":"Cause of Death Reason Type","preferredDefinition":"The circumstance or condition that results in the death of a living being.:An explanation of the cause of some phenomenon or action.:Something distinguishable as an identifiable class based on common qualities.","longName":"C81239:C25638:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cause of Death","conceptCode":"C81239","definition":"The circumstance or condition that results in the death of a living being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10659971-658A-DCF8-E050-BB89AD430723","latestVersionIndicator":"Yes","beginDate":"2015-03-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-03","modifiedBy":"ONEDATA","dateModified":"2015-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"21873A93-CDB7-A898-E050-BB89AD4354B4","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-10-07","modifiedBy":"MALUMK","dateModified":"2021-01-04","changeDescription":".Added PV for 4100r3. AK 11/10/17 Added PV \"COVID-19 (SARS-CoV-2)\". AK 2020-3-27. Added PVs for 2900r5. 01/04/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964926","version":"1","longName":"2900r1: Recipient Death Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedClinicalInterpretation:value ","type":"HCT_BRIDG","context":"NHLBI"},{"name":"Contribution Cause of Death Reason Type","type":"System-Generated","context":"NHLBI"},{"name":"TPST_CODM_contrb_cause_death","type":"NMDP_FN","context":"NHLBI"},{"name":"CPST_CODM_contrb_cause_death","type":"NMDP_FN","context":"NHLBI"},{"name":"CPST_SRV_contrb_cause_death","type":"NMDP_FN","context":"NHLBI"},{"name":"death_mul_cod_contrb_cause_dth","type":"NMDP_FN","context":"NHLBI"},{"name":"death_ccod_contrb_cause_death","type":"NMDP_FN","context":"NHLBI"},{"name":"TPST_SRV_contrb_cause_death","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Contributing cause of death:","type":"Preferred Question Text","description":"Contributing cause of death:","url":null,"context":"NHLBI"},{"name":"Contributing:","type":"Alternate Question Text","description":"Contributing:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2769114","type":"BRIDG Mapping Path","description":"PerformedMedicalConditionResult [death] > AssessedResultRelationship > PerformedObservation [etiology] > PerformedClinicalInterpretation.value WHERE  PerformedMedicalConditionResult.value = \"Death\" AND AssessedResultRelationship.typeCode = \"etiology\"","url":null,"context":"NHLBI"},{"name":"Contributing cause of death","type":"Alternate Question Text","description":"Contributing cause of death","url":null,"context":"NHLBI"},{"name":"Contributing cause of death","type":"Application Standard Question Text","description":"Contributing cause of death","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9DB25F6-41F0-956C-E040-BB89AD437FC7","latestVersionIndicator":"Yes","beginDate":"2015-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-05-20","modifiedBy":"KUMMEROA","dateModified":"2019-06-06","changeDescription":".Alt name \"cause_dth_contrib_1\"  removed due to being used on v1.0. AK 7/27/16 Added Alt name for 2900r4. AK 12/13/18 Added FN for 2450. AK 6/6/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}